We are live on
!
Find out more
enGene Therapeutics
ENGN
ENGN
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
26
Royal Bank of Canada
Toronto,
Ontario, Canada
| $75K | – | – | – |
|
27
UBS Group
Zurich,
Switzerland
| $31.8K | +$43.2K | +3,370 | New |
|
28
Wells Fargo
San Francisco,
California
| $9.17K | +$12.5K | +972 | New |
|
|
ACM
29
ADAR1 Capital Management
Austin,
Texas
| $5.66K | +$7.7K | +600 | New |
|
30
Morgan Stanley
New York
| $547 | +$641 | +50 | +625% |
|
|
CC
31
Commodore Capital
New York
| – | -$21.2M | -1,250,000 | Closed |
|
|
DM
32
Deerfield Management
New York
| – | -$13.6M | -800,000 | Closed |
|
|
ACP
33
Altitude Crest Partners
Stamford,
Connecticut
| – | -$2.04M | -120,289 | Closed |
|
|
PAMP
34
Polar Asset Management Partners
Toronto,
Ontario, Canada
| – | -$1.1M | -65,225 | Closed |
|
|
CSS
35
Cubist Systematic Strategies
Stamford,
Connecticut
| – | -$165K | -9,757 | Closed |
|
36
JP Morgan Chase
New York
| – | -$4.9K | -289 | Closed |
|
37
Qube Research & Technologies (QRT)
London,
United Kingdom
| – | -$237 | -14 | Closed |
|